Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F3G2N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,071
Award facts
- Contract value 100% obligated
- $19,070.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $19,070.64, was awarded on January 16, 2026, to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25 (a combination respiratory medication for chronic obstructive pulmonary disease) to support federal medical procurement needs. The award was made by the Defense Logistics Agency without a set-aside designation, indicating the contract was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill performance at its corporate office location in Conshohocken. The company operates as a subsidiary of Cencora, Inc., which holds the larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026.
This delivery order represents a task order exercise under AmerisourceBergen's existing indefinite delivery contract with the Defense Logistics Agency, a critical vehicle for supplying pharmaceutical products and medical commodities to military healthcare systems worldwide. The company's established relationship with the DLA Troop Support Medical and demonstrated capability in fulfilling federal pharmaceutical procurement requirements across multiple therapeutic domains positioned it to receive this award. The contract carries a completion date of January 20, 2026, and employs firm fixed-price pricing, consistent with the typical structure of federal pharmaceutical procurement through the DLA supply chain.
Quick answers
Who was awarded contract SPE2DR26F3G2N?
SPE2DR26F3G2N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F3G2N worth?
The government has obligated $19,071 on SPE2DR26F3G2N.
Is contract SPE2DR26F3G2N an order under another contract?
Yes. SPE2DR26F3G2N is a delivery order under SPE2DR25D3001, an indefinite delivery contract.
Was contract SPE2DR26F3G2N competed?
The extent of competition for SPE2DR26F3G2N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award